1/6
07:25 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Craig Hallum from a "hold" rating to a "strong-buy" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Craig Hallum from a "hold" rating to a "strong-buy" rating.
1/5
01:48 pm
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $3.00 to $5.00. They now have an "equal weight" rating on the stock.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $3.00 to $5.00. They now have an "equal weight" rating on the stock.
1/5
08:33 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $8.00 price target on the stock.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $8.00 price target on the stock.
1/5
06:01 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.
1/3
05:42 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/2
09:39 am
irwd
Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug [Yahoo! Finance]
High
Report
Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug [Yahoo! Finance]
1/2
07:05 am
irwd
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
High
Report
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
12/16
04:38 pm
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/29
06:00 pm
irwd
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
Neutral
Report
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
11/26
04:06 pm
irwd
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]
Medium
Report
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]
11/11
09:44 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $1.00 to $3.00. They now have an "equal weight" rating on the stock.
High
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $1.00 to $3.00. They now have an "equal weight" rating on the stock.
11/10
07:33 am
irwd
Ironwood Pharmaceuticals Non-GAAP EPS of $0.24 beats by $0.12, revenue of $122.06M beats by $46.36M [Seeking Alpha]
High
Report
Ironwood Pharmaceuticals Non-GAAP EPS of $0.24 beats by $0.12, revenue of $122.06M beats by $46.36M [Seeking Alpha]
11/10
07:05 am
irwd
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
High
Report
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
11/6
06:56 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.